pipeline

Illustration of the concept of layoff and downsizing of staff

Biomea cuts staff, drops leukemia asset in metabolic shift

Biomea is homing in on lead asset icovamenib, a menin inhibitor designed to address the underlying cause of diabetes, and a preclinical GLP-1 agonist.

Darren Incorvaia May 5, 2025 6:59pm

reshuffle pipeline target reorganize shift change

Recursion streamlines pipeline following merger with Exscientia

May 5, 2025 11:00am

AstraZeneca culls neuroscience meds in Q1 clear-out

Apr 29, 2025 7:08am

Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm

Evotec axes 30% of assets as cost-cutting push hits pipeline

Apr 17, 2025 9:45am

Cyclacel sheds clinical asset in effort to stop cash spiral

Apr 2, 2025 6:01pm